Dexa Group
Awards Earned
Primaniyarta
Award
Ministry
of Trade
of Trade
2005 • 2017-2019 • 2021
Indonesia's Most
Admired Companies
Warta
Ekonomi
Ekonomi
2017-2022
Top Brand
for Kids
Marketing
Magazine
Magazine
2009-2020 • 2022-2024
Outstanding Corporate
Innovator
Product Development and
Management Association
Management Association
2018
Indonesia Halal
Industry Awards
Ministry
of Industry
of Industry
2022 • 2024-2025
Halal
Award
LPPOM
MUI
MUI
2023
Anugerah
Ekonomi Hijau
Detikcom
2025
Indonesia Industry 4.0
Readiness Index
Ministry
of Industry
of Industry
2025
BPOM Achievement
Award
Food and Drug
Agency Indonesia
Agency Indonesia
2026
Dexa means Quality
Our name is inspired by the Greek word δέκα, meaning “ten” — a universal symbol of perfection. Even today, we strive to uphold that same high standard. This is why, for millions of people across 14 countries, Dexa signifies quality.
Integrative Modern Natural Medicine
We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.
Dexa: A Snapshot
Employees
Patents
Trademarks
Pharmacies Covered Directly
International Alliances
Marketing Authorisations
Latest News
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
23 September 2026
Dharma Dexa Implements “Deal with Care” for Disaster-Affected Communities in 2026
JAKARTA — Amid a series of natural disasters impacting various regions across Indonesia throughout 2026, Dexa Group, through its Corporate Social Initiative Dharma Dexa, continues to strengthen its commitment to safeguarding health and inspiring hope for affected communities. This step marks part of Dexa Group's 57th-anniversary spirit to extend meaningful…
22 September 2026
OGB Dexa Consistently Strengthens Access to Quality Medicines for Indonesia
JAKARTA – For more than three decades, Dexa Group has consistently contributed to providing quality medicines for the Indonesian people through Obat Generik Berlogo/OGB (unbranded generics) Dexa. Today, OGB Dexa produces more than 2 billion units annually with over 140 SKUs to support the National Health Insurance (JKN) program. This…
22 September 2026
Inlacin® Proves Quality of Scientific Phytopharmaceuticals for PMOS Management
JAKARTA — Globally, the condition long known as polycystic ovary syndrome (PCOS) is estimated to affect more than 170 million women, or approximately one in eight women of reproductive age. The vast prevalence and far-reaching impact of this condition led to a global consensus published in The Lancet in 2026,…
16 September 2026
Dexa Group Molecular Pharmacologist Prof. Raymond Tjandrawinata Earns Summa Cum Laude Doctorate in Law, Proposes Equitable Pharmaceutical Patent Model
JAKARTA – Prof. Raymond Tjandrawinata, Professor of Molecular Pharmacology at Atma Jaya University and Molecular Pharmacologist at Dexa Group, has successfully completed his Doctor of Law degree at Universitas Pelita Harapan (UPH), graduating with the distinction of Summa Cum Laude His doctoral research brings together his expertise in pharmaceutical science and…